Honorable Rafael Anchia, Chair, House Committee on International Trade & Intergovernmental Affairs
FROM:
Ursula Parks, Director, Legislative Budget Board
IN RE:
HB4002 by Burrows (Relating to an interim study regarding international price discrimination in pharmaceuticals.), As Introduced
No significant fiscal implication to the State is anticipated.
The bill would establish a joint interim committee to study and review the impacts of international pharmaceutical price discrimination on the people of Texas as well as on the state government. The bill would require the committee to be composed of the members of the International Trade and Intergovernmental Affairs Committee of the House of Representatives and the Intergovernmental Relations Committee of the Senate. The bill would require the Texas Legislative Council (TLC) to provide legal and policy research, bill drafting, and statistical analysis services to the committee. The bill specifies that Senate and House contingent expense funds would reimburse committee member expenses. The bill would require the committee to report its findings no later than January 6, 2017 and would abolish the committee on January 12, 2017.
Based on information provided by TLC, duties and responsibilities associated with implementing the provisions of the bill could be accomplished bill within existing resources. Implementing the provisions of the bill is not expected to result in a significant fiscal impact to either the Senate or the House of Representatives.
Local Government Impact
No fiscal implication to units of local government is anticipated.